SEARCH

SEARCH BY CITATION

References

  • 1
    Gines P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballerria J, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122128.
  • 2
    Rink CH, Haeting J, Nilius R. Prognosis assessment in patients with liver cirrhosis [Abstract]. Hepatogastroenterology 1990; 37 (suppl II): A86, 514.
  • 3
    Jessy J Mans AM, DeJoseph MR, Hawkins RA. Hyperammonenmia causes many of the changes found after portocaval shunting. Biochem J 1990; 272: 311317.
  • 4
    Hawkins RA, Jessy J. Hyperammonemia does not impair brain function in the absence of net glutamine synthesis. Biochem J 1991; 277: 697703.
  • 5
    Norenberg MD, Baker L, Norenberg LOB, Blicharska J, Bruce-Gregorius JH, Neary JT. Ammonia-induced astrocyte swelling in primary culture. Neurochem Res 1991; 16: 833836.
  • 6
    Dombro RS, Hutson DG, Norenberg MD. The action of ammonia on astrocyte glycogen and glycogenolysis. Mol Chem Neuropathol 1993; 19: 259268.
  • 7
    Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammo-nemic rats. Am J Physiol 1991; 261: H825H829.
  • 8
    Häussinger D, Laubenberger J, Vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gas-troenterology 1994; 107: 14751480.
  • 9
    Conn HO, Lieberthal MM. The hepatic coma syndromes and lactulose. Baltimore: Williams and Wilkins, 1979: 1121.
  • 10
    Bircher J. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1966; 1: 890893.
  • 11
    Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. Dig Dis 1978; 23: 398408.
  • 12
    Riggio O, Balducci G, Ariosto F, Merli M, Tremiterra S, Ziparo V, Capoc-cacia L. Lactitol in the treatment of chronic hepatic encephalopathy-a randomized cross-over comparison with lactulose. Hepatogastroenterology 1990; 37: 524527.
  • 13
    Uribe M, Conn HO. Dietary management of portal-systemic encephalopathy. In: ConnHO, BircherJ, eds. Hepatic Encephalopathy: Syndromes and Therapies. Bloomington, IL: Medi-Ed Press, 1994: 331350.
  • 14
    Kaiser S, Gerok W, Haussinger D. Ammonia and glutamine metabolism in human liver slices: new aspects of the pathogenesis of hyper ammonemia in chronic liver disease. Eur J Clin Invest 1988; 18: 535542.
  • 15
    Häussinger D, Gerok W. Hepatocyte heterogeneity in ammonia metabolism: Impairment of glutamine synthetase in CCL4induced liver cell necrosis with no effect on urea synthesis. Chem Biol Interact 1984; 48: 191193.
  • 16
    Gebhardt R, Reichen J. Changes in distribution and activity of glutamine synthetase in CCL4induced liver cirrhosis in the rat: potential role in hy-perammonemia. Hepatology 1994; 20: 684691.
  • 17
    Salvatore F, Scoppa P, Cozzolina D. Protective effect of ornithine and aspartic acid in chronic carbon tetrachloride intoxication. Clin Chim Acta 1959; 4: 728732.
  • 18
    Salvatore F, Cimino F, d'Ayello-Caracciolo M, Cittadini D. Mechanism of the protection by L-ornithine-L-aspartate mixture and by L-arginine in ammonia intoxication. Arch Biochem Biophys 1964; 107: 499508.
  • 19
    Sioya A, Kuraishi K, Kakimoto M, Tamama Y. Pharmacological study on L-ornithine-L-aspartate. Jap J Pharmacol 1964; 14: 201214.
  • 20
    Cohen NS, Chia-Wei Chung, Rijman L. The effects of ornithine on mito-chondrial carbamyl phosphate synthesis. J Biol Chem 1980; 255: 1024810255.
  • 21
    Goodman MW, Zieve L, Konstantinides, Cerra FB. Mechanism of arginine protection against ammonia intoxication in the rat. Am J Physiol 1984; 247: G290G295.
  • 22
    Gebhardt R, Beckers G, Gaunitz F, Haupt W, Jonitza D, Klein S, Scheja L. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels. J Pharmacol Exp Ther 1997 (submitted).
  • 23
    Zieve L, Lyftogt C, Raphael D. Ammonia toxicity: comparative protective effect of various arginine and ornithine derivatives, aspartate, benzoate, and carbamyl glutamate. Metab Brain Dis 1986; 1: 2535.
  • 24
    Leonhardt H, Bungert HJ. Therapie der schweren Hyper ammoniamie. Med Klin 1972; 67: 10521056.
  • 25
    Müting D, Reikowski J. Kontrollierte Studie hber die Wirkung einer oral verabreichten ammoniaksenkenden Aminosaure Ornithin-Aspartat auf Leber- und Pankreasfunktion bei Leberzirrhosekranken. Therapiewoche 1980; 30: 59905996.
  • 26
    Henglein-Ottermann D. DerEinfluβ Von Ornithin-Aspartat auf die exper-imentell erzeugte Hyper ammoniämie. Klinisch-experimentelle Studie. Ther Gegenw 1976; 115: 15041518.
  • 27
    Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmüller E, Holm E. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with liver cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 1993; 19: 424430.
  • 28
    Ganda OP, Ruderman NB. Muscle nitrogen metabolism in chronic hepatic insufficiency. Metabolism 1976; 25: 427435.
  • 29
    Butterworth RF, Girard G, Giguère JF. Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis. J Neurochem 1988; 51: 486490.
  • 30
    Girard G, Butterworth RF. Effect of portocaval anastomosis on glutamine synthetase activities in liver, brain, and skeletal muscle. Dig Dis Sci 1992; 37: 11211126.
  • 31
    Häussinger D. Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogen-esis in perfused rat liver. Eur J Biochem 1983; 133: 269274.
  • 32
    Gebhardt R, Mecke D. Heterogeneous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. European Molecular Biological Organisation Journal 1983; 2: 557560.
  • 33
    Gaasbeek-Janzen JW, Lamers WH, Moorman AFM, DeGraaf A., Los AJ, Charles R. Immunohistochemical localization of carbarnoylphosphate syn-thetase (ammonia) in adult rat liver: evidence for a heterogeneous distribution. J Histochem Cytochem 1984; 32: 557564.
  • 34
    Stoll B, McNelly S, Buscher HP, Haussinger D. Functional hepatocyte heterogeneity in glutamate, aspartate and α-ketoglutarate uptake: a his-toautoradiographical study. Hepatology 1991; 13: 247253.
  • 35
    Stoll B, Haussinger D. Functional hepatocyte heterogeneity: vascular oxo-glutarate is almost exclusively taken up by perivenous glutamine-synthe-tase-containing hepatocytes. Eur J Biochem 1989; 181: 709716.
  • 36
    Stoll B, Haussinger D. Hepatocyte heterogeneity in uptake and metabolism of malate and related dicarboxylates in perfused rat liver. Eur J Biochem 1991; 195: 121129.
  • 37
    Bung PA, Goldstein L, Newsholme EA. Glutamine synthetase activity of muscle in acidosis. Biochem J 1983; 216: 523525.
  • 38
    Albrecht J, Hilgier W, Januszewski S, Kapuscinski A, Quack G. Increase of the brain uptake index for L-ornithine in rats with hepatic encephalopathy. Neuroreport 1994; 5: 671673.
  • 39
    Vogels BAPM, Karlsen OT, Bovée WMMJ, Chamuleau RAFM. Orni-thine treatment of hyperammonemia induced encephalopathy: the effi-cacy and mechanism studied by in vivo brain 1H-MR spectroscopy [Abstract]. Proceedings of the Society of Magnetic Resonance and the European Society for Magnetic Resonance in Medicine and Biology, Nice 1995; 1759.
  • 40
    Conn HO. Trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22: 541550.
  • 41
    Da Fonseca-Wollheim F. Direkte Plasmaammoniakbestimmung ohne En-teiweissung. J Clin Chem Clin Biochem 1973; 11: 421431.
  • 42
    Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9: 811818.
  • 43
    Kleijnen J, De Craen A, Van Everdingen J, Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 1994; 344: 13471349.
  • 44
    Rothman KJ, Michels KB. Sounding board. The continuing unethical use of placebo controls. N Engl J Med 1994; 331: 394397.
  • 45
    Girard G, Giguere JF, Butterworth RF. Region-selective reductions in activities of glutamine synthetase in rat brain following portocaval anastomosis. Metab Brain Dis 1993; 8: 207215.